Ticker · CUSIP 13057Q305
Holders (tracked)
12
Combined shares
4,613,594
Combined value
$203.01M
Last close
$66.87
Quarter
2025Q4
Tracked holders · last 8 quarters
Flat over the last 8 quarters.
Price is +52.0% vs the avg quarter-end implied price across tracked holders.
SEC event timeline
20 events
- T. Rowe Price added2026-02-17+10,677 shares · 2025Q413F
- Ken Griffin (Citadel Advisors) added2026-02-17+857,340 shares · 2025Q413F
- D.E. Shaw & Co. trimmed2026-02-17−161,851 shares · 2025Q413F
- AQR Capital Management trimmed2026-02-17−146,326 shares · 2025Q413F
- Two Sigma Investments trimmed2026-02-17−16,771 shares · 2025Q413F
- Izzy Englander (Millennium Mgmt) trimmed2026-02-17−263,953 shares · 2025Q413F
- Steve Cohen (Point72) exited2026-02-17−174,700 shares · 2025Q413F
- Jeremy Grantham (GMO) trimmed2026-02-17−120,500 shares · 2025Q413F
- +22,387 shares · 2025Q413F
- Renaissance Technologies added2026-02-12+14,639 shares · 2025Q413F
- −106,082 shares · 2025Q313F
- Two Sigma Investments added2025-11-14+293,248 shares · 2025Q313F
- D.E. Shaw & Co. added2025-11-14+132,711 shares · 2025Q313F
- T. Rowe Price added2025-11-14+4,557 shares · 2025Q313F
- AQR Capital Management added2025-11-14+302,512 shares · 2025Q313F
- Steve Cohen (Point72) added2025-11-14+163,200 shares · 2025Q313F
- Izzy Englander (Millennium Mgmt) trimmed2025-11-14−115,594 shares · 2025Q313F
- Howard Marks (Oaktree Capital) trimmed2025-11-13−682,251 shares · 2025Q313F
- Jeremy Grantham (GMO) trimmed2025-11-13−174,100 shares · 2025Q313F
- Renaissance Technologies trimmed2025-11-13−139,100 shares · 2025Q313F
Insider activity
No insider transactions in the last 30 days.
Follow-the-investor returns
If you'd copied each holder of CRC…
Cost basis inferred from 13F share-delta history. Sorted by % return on the position they're still holding.
| Investor | First in | Cost basis | Return | Position value today |
|---|---|---|---|---|
| T. Rowe Price | 2021Q2 | $14.05 | +376.1% | $4.9M |
| Renaissance Technologies | 2021Q2 | $43.40 | +54.1% | $29.4M |
| Ray Dalio (Bridgewater Associates) | 2025Q4 | $44.71 | +49.6% | $1.5M |
| Ken Griffin (Citadel Advisors) | 2020Q4 | $44.91 | +48.9% | $455K |
| Ken Griffin (Citadel Advisors) | 2020Q4 | $44.91 | +48.9% | $455K |
| Ken Griffin (Citadel Advisors) | 2020Q4 | $44.91 | +48.9% | $455K |
| Izzy Englander (Millennium Mgmt) | 2020Q4 | $46.20 | +44.7% | $642K |
| D.E. Shaw & Co. | 2021Q2 | $48.56 | +37.7% | $19.3M |
| Jeremy Grantham (GMO) | 2021Q4 | $49.57 | +34.9% | $66.5M |
| AQR Capital Management | 2021Q3 | $49.87 | +34.1% | $26.0M |
| Two Sigma Investments | 2021Q1 | $50.48 | +32.5% | $30.6M |
| Howard Marks (Oaktree Capital) | 2021Q1 | $52.09 | +28.4% | $46.4M |
Who moved on this name in 2025Q4
13F transactions reported for the latest quarter, grouped by direction.
New positions1
- Ray Dalio (Bridgewater Associates)+22,387$1.0M
Added to3
- Ken Griffin (Citadel Advisors)+857,340$38.3M
- Renaissance Technologies+14,639$655K
- T. Rowe Price+10,677$477
Trimmed5
- Izzy Englander (Millennium Mgmt)−263,953$11.8M
- D.E. Shaw & Co.−161,851$7.2M
- AQR Capital Management−146,326$6.5M
- Jeremy Grantham (GMO)−120,500$5.4M
- Two Sigma Investments−16,771$750K
Exited1
- Steve Cohen (Point72)−174,700$9.3M
Institutional ownership over time
Distinct super-investors holding this ticker · combined dollar value, by quarter.
| Quarter | Holders | Combined value |
|---|---|---|
| 2022Q1 | 12 | $482.6M |
| 2022Q2 | 12 | $345.4M |
| 2022Q3 | 12 | $319K |
| 2022Q4 | 13 | $293.6M |
| 2023Q1 | 13 | $249.8M |
| 2023Q2 | 11 | $567.0M |
| 2023Q3 | 11 | $699.2M |
| 2023Q4 | 12 | $756.7M |
| 2024Q1 | 13 | $728.4M |
| 2024Q2 | 12 | $750.9M |
| 2024Q3 | 15 | $288.3M |
| 2024Q4 | 13 | $239.3M |
| 2025Q1 | 14 | $249.7M |
| 2025Q2 | 13 | $231.7M |
| 2025Q3 | 12 | $246.5M |
| 2025Q4 | 12 | $203.0M |
Who owns CRC
12 super-investors · 2025Q4
Tracked stake
4.61M
shares
Combined value
$203M
% of shares outstanding
—
shares-out unknown
Quarter action mix
New1Added5Trim5Held1
| # | Manager | Shares | Value |
|---|---|---|---|
| 1 | Ken Griffin Citadel Advisors | 1.21M | $54M |
| 2 | Jeremy Grantham GMO | 994.9K | $44M |
| 3 | Howard Marks Oaktree Capital | 694.5K | $31M |
| 4 | Two Sigma Investments | 458.3K | $20M |
| 5 | Renaissance Technologies | 439.6K | $20M |
| 6 | AQR Capital Management | 388.3K | $17M |
| 7 | D.E. Shaw & Co. | 288.4K | $13M |
| 8 | Ken Griffin Citadel Advisors | 31.0K | $1M |
| 9 | Ray Dalio Bridgewater Associates | 22.4K | $1M |
| 10 | Izzy Englander Millennium Mgmt | 9.6K | $429K |
| 11 | Ken Griffin Citadel Advisors | 6.8K | $304K |
| 12 | T. Rowe Price | 73.1K | $3K |
Recent moves
20 transactions
- −16,771 · 2025Q4
- −263,953 · 2025Q4
- −120,500 · 2025Q4
- +857,340 · 2025Q4
- TRIMD.E. Shaw & Co.−161,851 · 2025Q4
- −174,700 · 2025Q4
- +10,677 · 2025Q4
- −146,326 · 2025Q4
- +22,387 · 2025Q4
- +14,639 · 2025Q4
- −106,082 · 2025Q3
- +132,711 · 2025Q3
- +293,248 · 2025Q3
- +163,200 · 2025Q3
- +4,557 · 2025Q3
- −115,594 · 2025Q3
- +302,512 · 2025Q3
- −174,100 · 2025Q3
- −139,100 · 2025Q3
- −682,251 · 2025Q3
Embed this chart
Paste this iframe anywhere to embed the live CRC chart.
<iframe src="https://openstocks.me/embed/stock/CRC" width="100%" height="480" frameborder="0" loading="lazy" title="CRC chart by OpenStocks" style="border:0;border-radius:12px;background:transparent"></iframe>